Published in Psychol Med on January 01, 2002
Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia. Schizophr Bull (2006) 1.53
Early and broadly defined psychosis risk mental states. Schizophr Res (2010) 1.01
The Edinburgh High Risk Study: current status and future prospects. World Psychiatry (2003) 0.87
Children of parents with affective and nonaffective psychoses: a longitudinal study of behavior problems. Am J Psychiatry (2010) 0.83
Cross-informant agreement on child and adolescent withdrawn behavior: a latent class approach. Child Psychiatry Hum Dev (2013) 0.80
Candidate gene associations with withdrawn behavior. J Child Psychol Psychiatry (2013) 0.80
Does a parent-report measure of behavioral problems enhance prediction of conversion to psychosis in clinical high-risk adolescents? Schizophr Res (2011) 0.79
Psychosis risk screening in clinical high-risk adolescents: a longitudinal investigation using the Child Behavior Checklist. Schizophr Res (2014) 0.79
Stability and prediction of schizophrenia from adolescence to adulthood. Eur Child Adolesc Psychiatry (2005) 0.78
Effect of theory of mind and peer victimization on the schizotypy-aggression relationship. NPJ Schizophr (2016) 0.75
Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model. Biol Psychiatry (2016) 0.75
School-associated problem behavior in childhood and adolescence and development of adult schizotypal symptoms: a follow-up of a clinical cohort. J Abnorm Child Psychol (2014) 0.75
Temperamental Characteristics of Withdrawn Behavior Problems in Children. Child Psychiatry Hum Dev (2017) 0.75
Psychological autopsy studies of suicide: a systematic review. Psychol Med (2003) 4.97
Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ (1994) 3.33
Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet (1976) 3.14
Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol (1992) 2.67
Secondhand smoke exposure and risk following the Irish smoking ban: an assessment of salivary cotinine concentrations in hotel workers and air nicotine levels in bars. Tob Control (2005) 2.63
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut (2010) 2.47
Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet (1999) 2.47
Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry (2009) 2.46
Immunological events in regressing genital warts. Am J Clin Pathol (1994) 2.37
Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A (1997) 2.37
Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. N Engl J Med (1987) 2.37
Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study. Br J Psychiatry (2003) 2.31
A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J Cell Biol (1995) 2.30
Tuberculosis of the cervix: case presentation and a review of the literature. Sex Transm Infect (2002) 2.27
Presenilin-I, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease. Lancet (1997) 2.06
Complications of pregnancy and delivery in relation to psychosis in adult life: data from the British perinatal mortality survey sample. BMJ (1991) 2.03
Implementing evidence-based psychiatry: whose responsibility? Br J Psychiatry (2001) 1.99
People at risk of schizophrenia. Sample characteristics of the first 100 cases in the Edinburgh High-Risk Study. Br J Psychiatry (1999) 1.98
Cancer chemotherapy and quality of life. BMJ (1992) 1.97
A new method for the concentration of Cryptosporidium oocysts from water. J Appl Bacteriol (1993) 1.95
Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. Am J Psychiatry (1997) 1.94
Service provision for people with schizophrenia. II. Role of the general practitioner. Br J Psychiatry (1997) 1.88
Depression after stroke and lesion location: a systematic review. Lancet (2000) 1.87
Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users. Br J Psychiatry (1999) 1.86
The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group. J Clin Oncol (1993) 1.79
The dementia of dementia praecox. Acta Psychiatr Scand (1978) 1.79
The Northwick Park electroconvulsive therapy trial. Lancet (1981) 1.79
Chronic fatigue syndrome: prevalence and outcome. BMJ (1994) 1.77
Working memory in schizophrenia: a meta-analysis. Psychol Med (2008) 1.76
Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry (1986) 1.74
Schizophrenic patients discharged from hospital--a follow-up study. Br J Psychiatry (1984) 1.71
Dangerous behaviour preceding first admissions for schizophrenia. Br J Psychiatry (1992) 1.71
The effects of a neuregulin 1 variant on white matter density and integrity. Mol Psychiatry (2007) 1.68
Acetylator status and response to phenelzine in depressed patients. Lancet (1973) 1.67
Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychol Med (1980) 1.66
Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia. Biol Psychiatry (2001) 1.59
New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet (1997) 1.55
A MRI study of ocular hypertelorism in individuals at high risk of developing schizophrenia. Schizophr Res (2001) 1.54
Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol Med (2000) 1.52
Concordance by sex in sibling pairs with schizophrenia is paternally inherited. Evidence for a pseudoautosomal locus. Br J Psychiatry (1989) 1.50
Unsuspected organic disease in chronic schizophrenia demonstrated by computed tomography. J Neurol Neurosurg Psychiatry (1980) 1.48
Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet (1978) 1.47
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol (2012) 1.46
Risk factors of female HIV-seropositive patients attending the clinic for sexually transmitted diseases at St Mary's Hospital, London. Int J STD AIDS (1990) 1.46
Red cell genetic abnormalities in Peninsular Arabs: sickle haemoglobin, G6PD deficiency, and alpha and beta thalassaemia. J Med Genet (1986) 1.44
Segregation of cognitive and emotional function in the prefrontal cortex: a stereotactic meta-analysis. Neuroimage (2004) 1.44
Guidelines for the management of vulvodynia. Br J Dermatol (2010) 1.44
Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch Gen Psychiatry (1982) 1.44
Small intestine permeability in schizophrenia. Br J Psychiatry (1989) 1.41
Chronic fatigue syndrome. Lancet (1994) 1.40
Developing training themes from HRH's delivery. Br J Psychiatry (1992) 1.38
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry (1989) 1.38
Psychosocial implications of recurrent genital herpes simplex virus infection. Genitourin Med (1988) 1.37
The Northwick Park Study of first episodes of schizophrenia. I. Presentation of the illness and problems relating to admission. Br J Psychiatry (1986) 1.36
Haloperidol versus placebo for schizophrenia. Cochrane Database Syst Rev (2006) 1.35
Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS). Psychol Med (1999) 1.34
Deficits in facial, body movement and vocal emotional processing in autism spectrum disorders. Psychol Med (2010) 1.33
Comparative trial of L-tryptophan and amitriptyline in depressive illness. Psychol Med (1976) 1.32
Obstetric complications and schizophrenia: a meta-analysis. Br J Psychiatry (1995) 1.31
Thalassaemia trait and pregnancy. J Clin Pathol (1985) 1.30
A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. Br J Cancer (1990) 1.28
A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry (1986) 1.27
Clinical features and management of recurrent balanitis; association with atopy and genital washing. Genitourin Med (1993) 1.26
Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis. Eur Psychiatry (2012) 1.25
Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. Mol Psychiatry (2010) 1.24
The effect of health status on patients' satisfaction with out-of-hours care provided by a family doctor co-operative. Fam Pract (2004) 1.23
Effect of social class at birth on risk and presentation of schizophrenia: case-control study. BMJ (2001) 1.21
Volumetric magnetic resonance imaging study of the brain in subjects with sex chromosome aneuploidies. J Neurol Neurosurg Psychiatry (1999) 1.20
fMRI correlates of state and trait effects in subjects at genetically enhanced risk of schizophrenia. Brain (2004) 1.20
Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma. Int J Cancer (1973) 1.18
Routine monitoring of Cryptosporidium oocysts in water using flow cytometry. J Appl Bacteriol (1993) 1.16
The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine. Psychopharmacologia (1976) 1.15
Hand transplantation: comparisons and observations of the first four clinical cases. Microsurgery (2000) 1.15
Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer. Ann Oncol (1993) 1.14
'Pfropfschizophrenie' revisited. Schizophrenia in people with mild learning disability. Br J Psychiatry (1998) 1.14
Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment. Br Med J (1975) 1.13
Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls. Psychiatry Res (2001) 1.12
Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Soc Psychiatry Psychiatr Epidemiol (2001) 1.12
Comparative trial of L-tryptophan and E.C.T. in severe depressive illness. Lancet (1974) 1.11
Compliance therapy for schizophrenia. Cochrane Database Syst Rev (2006) 1.11
Edinburgh high risk study--findings after four years: demographic, attainment and psychopathological issues. Schizophr Res (2000) 1.10
Neuroanatomy of comorbid schizophrenia and learning disability: a controlled study. Lancet (1999) 1.10